DK459486D0 - Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf - Google Patents

Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf

Info

Publication number
DK459486D0
DK459486D0 DK459486A DK459486A DK459486D0 DK 459486 D0 DK459486 D0 DK 459486D0 DK 459486 A DK459486 A DK 459486A DK 459486 A DK459486 A DK 459486A DK 459486 D0 DK459486 D0 DK 459486D0
Authority
DK
Denmark
Prior art keywords
sub
vitamin
granules
compounds
tablets
Prior art date
Application number
DK459486A
Other languages
English (en)
Other versions
DK167339B1 (da
DK459486A (da
Inventor
Seiji Izuhara
Nobuyuki Kitamori
Masaya Maeno
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16808227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK459486(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK459486D0 publication Critical patent/DK459486D0/da
Publication of DK459486A publication Critical patent/DK459486A/da
Application granted granted Critical
Publication of DK167339B1 publication Critical patent/DK167339B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyridine Compounds (AREA)
DK459486A 1985-10-07 1986-09-26 Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf DK167339B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22407985 1985-10-07
JP22407985 1985-10-07

Publications (3)

Publication Number Publication Date
DK459486D0 true DK459486D0 (da) 1986-09-26
DK459486A DK459486A (da) 1987-04-08
DK167339B1 DK167339B1 (da) 1993-10-18

Family

ID=16808227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK459486A DK167339B1 (da) 1985-10-07 1986-09-26 Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf

Country Status (11)

Country Link
US (1) US4868180A (da)
EP (1) EP0219276B1 (da)
JP (1) JPH0751504B2 (da)
KR (1) KR930008951B1 (da)
CN (1) CN1022024C (da)
AT (1) ATE77942T1 (da)
AU (1) AU587863B2 (da)
CA (1) CA1308024C (da)
DE (1) DE3685927T2 (da)
DK (1) DK167339B1 (da)
ES (1) ES2041641T3 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2689458B2 (ja) * 1988-02-09 1997-12-10 武田薬品工業株式会社 粒状ないし粉末状のビタミンｂ▲下１▼▲下２▼類含有組成物
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
DK0390435T3 (da) * 1989-03-29 1994-03-21 Takeda Chemical Industries Ltd Blanding indeholdende en forbindelse fra vitamin B gruppen, og fremstilling deraf
JP2591235B2 (ja) * 1989-03-30 1997-03-19 吉富製薬株式会社 アルキルシステインまたはその酸付加塩を含有する安定な錠剤
US5034389A (en) * 1989-07-28 1991-07-23 Coors Biotech, Inc. Riboflavin composition and method for production
DE3927810A1 (de) * 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
GB8922701D0 (en) * 1989-10-09 1989-11-22 Leung Lit Hung Compositions and methods for weight reduction
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
US5254551A (en) * 1990-04-30 1993-10-19 Kirk Paula S Flour fortification formulation comprising granulated riboflavin
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
DE4014262A1 (de) * 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP3011752B2 (ja) * 1990-10-23 2000-02-21 フロイント産業株式会社 徐放性製剤およびその製造方法
GB2252905B (en) * 1991-02-11 1995-05-10 Leung Lit Hung An agent for correcting a deficiency of androgenic steroids
GB2252729B (en) * 1991-02-13 1994-11-09 Bharat Sridhar Pancham Vitamin and/or mineral containing pharmaceutical compositions
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
US5534262A (en) * 1992-01-10 1996-07-09 Dobrotvorsky; Anatoly E. Pharmaceutical granulated composition and method for preparing same
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5635535A (en) * 1996-04-05 1997-06-03 Wagstaff; Robert K. Method for increasing blood glucose levels
JP4098376B2 (ja) * 1996-09-05 2008-06-11 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤特性の優れた水溶性ビタミン組成物およびその製造法
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules
JP2001031567A (ja) * 1999-05-20 2001-02-06 Takeda Chem Ind Ltd アスコルビン酸塩含有組成物
DE10032349A1 (de) * 2000-07-04 2002-01-17 Degussa Rieselfähige D-Pantothensäure und/oder deren Salze enthaltende Futtermittel-Additive und Verfahren zu deren Herstellung
IT1320776B1 (it) * 2000-08-07 2003-12-10 Giampiero Valletta Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
US6773733B2 (en) * 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
DE60225560T2 (de) * 2001-07-30 2009-04-02 Dsm Ip Assets B.V. Zusammensetzung enthaltend epigallocatechin-gallat
JP4519444B2 (ja) * 2003-10-31 2010-08-04 ライオン株式会社 口腔内崩壊錠
CA2589200A1 (en) * 2004-11-26 2006-06-01 Medicure International Inc. Formulations of pyridoxal -5'-phosphate and methods of preparation
FR2879403B1 (fr) * 2004-12-20 2007-05-11 Alept Sarl Soc Complement alimentaire destine a prevenir l'apparition des symptomes associes a la maladie d'alzheimer
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤
JP5198001B2 (ja) * 2006-06-23 2013-05-15 武田薬品工業株式会社 安定化された固形製剤
SI2164975T1 (sl) 2007-07-06 2012-06-29 Basf Se Postopek za proizvajanje koncentriranega vodnega glukoznega pripravka iz koruze
DE102007045038A1 (de) * 2007-09-13 2009-03-19 MEDICE Arzneimittel Pütter GmbH & Co. KG Arzneimittel zur Behandlung oder Prävention von Proteinurie
CN101632648A (zh) * 2008-07-23 2010-01-27 Ss制药株式会社 薄膜包衣制剂
MX351356B (es) * 2008-11-13 2017-10-04 Com S Car Borr S A De C V Kit de formulaciones farmaceuticas caracterizado por la presencia de oxigeno molecular.
JP2011063580A (ja) * 2009-06-30 2011-03-31 Kowa Co 組成物
JP5897916B2 (ja) * 2012-01-31 2016-04-06 アサヒフードアンドヘルスケア株式会社 ビタミン含有錠剤及びその製造方法
TW201402153A (zh) * 2012-04-04 2014-01-16 Lonza Ag 菸鹼醯胺粉末和其製備方法及裝置
US9510617B2 (en) 2012-04-13 2016-12-06 Frito-Lay North America, Inc. Micropellets of fine particle nutrients and methods of incorporating same into snack food products
US9271523B2 (en) 2012-05-23 2016-03-01 Dennis Williams Rotor assembly with one-piece finger member
CN103720660A (zh) * 2013-11-19 2014-04-16 华中药业股份有限公司 一种核黄素颗粒及其制备方法
JP6056064B2 (ja) * 2013-11-29 2017-01-11 国立大学法人 東京大学 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物
CN105581982A (zh) * 2014-10-23 2016-05-18 华中药业股份有限公司 一种烟酰胺颗粒剂及其制备方法
CN111012748B (zh) * 2018-10-10 2022-06-10 常州市第四制药厂有限公司 维生素b12制剂及其制备方法
CN112930166A (zh) * 2018-11-05 2021-06-08 重庆小丸生物科技股份有限公司 一种水溶性活性物颗粒及其制备方法和应用
CN109771383A (zh) * 2018-12-20 2019-05-21 华中药业股份有限公司 复合维生素b颗粒、复合维生素b片及其制备方法
CN111012755A (zh) * 2020-01-09 2020-04-17 仁和堂药业有限公司 维生素b6片的制备工艺
CN111110643A (zh) * 2020-01-09 2020-05-08 仁和堂药业有限公司 一种维生素b6片剂及其质量检测方法
CN111419808A (zh) * 2020-04-23 2020-07-17 河南海汇药物研究有限公司 一种维生素b6全粉末压片工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA678143A (en) * 1964-01-14 Hochberg Melvin Tablets for pharmaceutical use
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
US3493659A (en) * 1967-10-23 1970-02-03 Hoffmann La Roche Compositions and process for the production thereof
BE791458A (fr) * 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule
IL43853A0 (en) * 1973-02-16 1974-03-14 Sparamedica Ag Pharmaceutical compositions and their manufacture
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
EP0125252A1 (de) * 1982-11-16 1984-11-21 MOTSCHAN, Georges Neue verwendung eines einzelnen vitamins oder einer kombination verschiedener vitamine
US4486435A (en) * 1983-05-16 1984-12-04 Basf Wyandotte Corporation Spray-dried vitamin powders using hydrophobic silica
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPH0753663B2 (ja) * 1984-10-09 1995-06-07 武田薬品工業株式会社 チアミン塩の顆粒，その製造法および錠剤

Also Published As

Publication number Publication date
DE3685927T2 (de) 1992-12-24
US4868180A (en) 1989-09-19
ATE77942T1 (de) 1992-07-15
AU587863B2 (en) 1989-08-31
AU6291986A (en) 1987-04-09
JPS62174013A (ja) 1987-07-30
DK167339B1 (da) 1993-10-18
DK459486A (da) 1987-04-08
KR870003776A (ko) 1987-05-04
KR930008951B1 (ko) 1993-09-17
ES2041641T3 (es) 1993-12-01
JPH0751504B2 (ja) 1995-06-05
CA1308024C (en) 1992-09-29
EP0219276A2 (en) 1987-04-22
CN86106839A (zh) 1988-04-20
EP0219276A3 (en) 1988-09-21
DE3685927D1 (de) 1992-08-13
EP0219276B1 (en) 1992-07-08
CN1022024C (zh) 1993-09-08

Similar Documents

Publication Publication Date Title
DK459486D0 (da) Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf
ATE84705T1 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
DK163208C (da) Retard-praeparat af acemetacin og fremgangsmaade til fremstilling deraf
IE821861L (en) Pharmaceutical compositions
AU3394689A (en) Pharmaceutical compositions
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
JPH05503540A (ja) 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法
JPS52128210A (en) Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
DE3374404D1 (en) Trans-4-aminobenz(c,d)indol-5-ol derivatives, their salts, their preparation, their use as medicaments and compositions containing them
IL65787A0 (en) Antiviral pharmaceutical compositions containing alpha,alpha-dialkyl-adamantylamines
CA2403110A1 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
JPS52153977A (en) Synthesis of 5-fluorouracil and its derivatives
Ershoff Protective effects of cholestyramine in rats fed a low-fiber diet containing toxic doses of sodium cyclamate or amaranth
DE3277731D1 (en) Solid, strong alcaline compounds that contain active chlorine
JPS56150017A (en) Cholesteril lowering agent
JPS5278887A (en) Synthesis of n-(2-tetrahydrofuryl)-5-fluorouracil
JPS57209222A (en) Cardiac
AU553742B2 (en) Antibiotic feed agent for coccidiosis
ATE20521T1 (de) Antikatalytische zusaetze fuer brandverzoegerungsund feuerloeschpulver und diese enthaltende brandverzoegerungs- und feuerloeschpulver sowie verfahren zu ihrer herstellung.
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
GB1478020A (en) Composition for the treatment of asthma
JPS539315A (en) Preparation of hardly soluble pharmaceuticals
JPS57109722A (en) Antitumor agent containing deoxyfluorouridine benzyloxylated at 4-position
JPS53124609A (en) Stable drug composition containing digoxins

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired